Oscar Health (NYSE:OSCR) Shares Gap Up to $18.97

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $18.97, but opened at $20.60. Oscar Health shares last traded at $19.89, with a volume of 2,051,735 shares traded.

Analysts Set New Price Targets

OSCR has been the subject of several research reports. Wells Fargo & Company increased their target price on shares of Oscar Health from $12.00 to $20.00 and gave the company an "overweight" rating in a research note on Thursday, February 15th. TheStreet raised Oscar Health from a "d" rating to a "c-" rating in a report on Wednesday, February 21st. Raymond James assumed coverage on Oscar Health in a research note on Friday, March 22nd. They issued an "outperform" rating and a $20.00 target price for the company. Finally, The Goldman Sachs Group lifted their price target on shares of Oscar Health from $8.00 to $16.00 and gave the stock a "neutral" rating in a research note on Friday, February 9th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $13.50.

Oscar Health Stock Up 4.2 %

The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.37. The business has a 50-day simple moving average of $15.35 and a two-hundred day simple moving average of $11.86. The stock has a market capitalization of $4.54 billion, a P/E ratio of -16.47 and a beta of 1.66.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) EPS for the quarter, topping analysts' consensus estimates of ($0.74) by $0.08. Oscar Health had a negative return on equity of 29.99% and a negative net margin of 4.62%. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the company earned ($1.05) EPS. Oscar Health's revenue for the quarter was up 43.9% on a year-over-year basis. Equities research analysts forecast that Oscar Health, Inc. will post -0.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Institutional investors have recently modified their holdings of the stock. Sei Investments Co. raised its position in shares of Oscar Health by 100.0% during the first quarter. Sei Investments Co. now owns 42,998 shares of the company's stock worth $639,000 after acquiring an additional 21,497 shares during the last quarter. 12 West Capital Management LP acquired a new stake in shares of Oscar Health during the first quarter worth $2,779,000. Susquehanna Fundamental Investments LLC increased its holdings in Oscar Health by 14.9% in the first quarter. Susquehanna Fundamental Investments LLC now owns 51,780 shares of the company's stock valued at $770,000 after purchasing an additional 6,733 shares during the last quarter. Swiss National Bank lifted its stake in Oscar Health by 2.4% in the first quarter. Swiss National Bank now owns 263,800 shares of the company's stock valued at $3,923,000 after buying an additional 6,100 shares during the period. Finally, Avalon Trust Co bought a new position in Oscar Health during the first quarter worth about $69,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.